Literature DB >> 8878553

Proteasome-dependent regulation of p21WAF1/CIP1 expression.

M V Blagosklonny1, G S Wu, S Omura, W S el-Deiry.   

Abstract

Proteasome-dependent degradation of regulatory proteins is a known mechanism of cell cycle control. We found that the proteasome-specific inhibitor lactacystin (LC) induced expression of the cell cycle inhibitor p21WAF1/CIP1 in human cancer cells regardless of their p53 status. Both wild-type (wt) p53 and p21 protein levels increased by two hours in wt p53 containing cells, whereas mutant (mt) p53 levels decreased and the increase in p21 levels was delayed to 6 hr following inhibition of proteolysis by LC in mt p53 expressing cells. We found that wt but not mt p53 expressing cells increased p21 mRNA and p21-promoter reporter levels following LC exposure, suggesting transcriptional induction of p21. Inhibition of protein synthesis by cycloheximide demonstrated increased p21 protein half-life in the presence of LC in mutant p53 containing cells. p21 induction was correlated with the cytostatic effects of LC. The results suggest that p21 protein expression could be increased by transcriptional mechanisms as well as inhibition of proteolysis by LC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878553     DOI: 10.1006/bbrc.1996.1546

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  49 in total

Review 1.  Functional role of p21 during the cellular response to stress.

Authors:  M Gorospe; X Wang; N J Holbrook
Journal:  Gene Expr       Date:  1999

2.  A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.

Authors:  R Touitou; J Richardson; S Bose; M Nakanishi; J Rivett; M J Allday
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  The role of mRNA decay in p53-induced gene expression.

Authors:  Brian D Melanson; Reetesh Bose; Jeff D Hamill; Kristen A Marcellus; Elysia F Pan; Bruce C McKay
Journal:  RNA       Date:  2011-10-21       Impact factor: 4.942

4.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

5.  hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.

Authors:  S C Gehen; R J Staversky; R A Bambara; P C Keng; M A O'Reilly
Journal:  Oncogene       Date:  2008-03-10       Impact factor: 9.867

6.  Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent.

Authors:  Susan A J Vaziri; Dale R Grabowski; Jason Hill; Lisa R Rybicki; Robert Burk; Ronald M Bukowski; Mahrukh K Ganapathi; Ram Ganapathi
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

7.  Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.

Authors:  L E Johannessen; S L Knardal; I H Madshus
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

8.  Adenovirus E1A-regulated transcription factor p120E4F inhibits cell growth and induces the stabilization of the cdk inhibitor p21WAF1.

Authors:  E R Fernandes; J Y Zhang; R J Rooney
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

9.  N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) triggers MSH2 and Cdt2 protein-dependent degradation of the cell cycle and mismatch repair (MMR) inhibitor protein p21Waf1/Cip1.

Authors:  Thomas Jascur; Rati Fotedar; Serena Greene; Erin Hotchkiss; C Richard Boland
Journal:  J Biol Chem       Date:  2011-07-02       Impact factor: 5.157

10.  Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.

Authors:  Mathew L Coleman; Christopher J Marshall; Michael F Olson
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.